Tuesday, January 22, 2019

Recent data on opioids from the CDC



Study Shows Urban-Rural Split on Opioid Prescribing Rates; Putting the Numbers to Fentanyl Deaths in NYC

A new study just released from the CDC confirmed findings that opioid prescriptions were nearly twice as likely to occur among rural residents, compared to central metro areas. (GarcĂ­a MC, Heilig CM, Lee SH, et al. Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System — United States, 2014–2017. MMWR Morb Mortal Wkly Rep 2019;68:25–30. DOI: http://dx.doi.org/10.15585/mmwr.mm6802a1.)  The study analyzed data from the AthenaHealth electronic medical record system. This cloud based EMR is used by about 100,000 providers serving 86 million patients. De-identified data were used for the study.

The first take-home message is that there is a lot of opioid prescriptions flying out of rural providers’ offices. At the last data point in 2017, about 9% of patients in non-core and micropolitan areas, whereas only 5% received a prescription in central metropolitan areas.

A second major finding was that the percentage of patients in metro areas remained remarkably stable, at 5%, whereas in rural areas, it got as high as 10.3%, before starting to drop since 2016. 

The authors correctly point out that there are many possible reasons for such a finding. However, the split between rural and urban areas is solid.

In another article from the same issue (Colon-Berezin C, Nolan ML, Blachman-Forshay J, Paone D. Overdose Deaths Involving Fentanyl and Fentanyl Analogs — New York City, 2000–2017. MMWR Morb Mortal Wkly Rep 2019;68:37–40. DOI: http://dx.doi.org/10.15585/mmwr.mm6802a3,) deaths from fentanyl overdose increased dramatically. In 2012, about 2% of deaths involved fentanyl, but by 2017, fentanyl involvement was present in 57% of overdose deaths in New York City.

The CDC's Morbidity and Mortality Weekly is available to all here


No comments:

Post a Comment

Comments are welcome.